ELUT Stock Analysis: Buy, Sell, or Hold?
ELUT - Elutia Inc. Class A Common Stock
$0.94
-0.01 (-0.99%)
âŧ
5d:
-3.52%
30d:
+1.24%
90d:
-18.84%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ELUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ELUT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ELUT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ELUT is currently trading at $0.94, which is considered slightly high relative to its 30-day fair value range of $0.86 to $0.95.
Technical Outlook: Technically, ELUT is in a strong downtrend. Immediate support is located at $0.76, while resistance sits at $1.00.
Market Sentiment: ELUT scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.00 (+425.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELUT is in a strong downtrend. Immediate support is located at $0.76, while resistance sits at $1.00.
Market Sentiment: ELUT scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.00 (+425.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.86 -
$0.95
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 425.8% below Wall St target ($5.00)
- WARNING: Composite score 34/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.86 -
$0.95
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.76
Resistance Level
$1.00
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.76
Wall Street Target
$5.00
(+425.8%)
Revenue Growth (YoY)
-11.6%
Profit Margin
426.9%
Share & Embed Analysis
Last updated: August 24, 2026 2:08 PM ET
Data refreshes hourly during market hours. Next update: 3:08 PM
Data refreshes hourly during market hours. Next update: 3:08 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELUT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 46 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 45 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 33 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 54 HOLD |
